K. Machiels

发表

Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD

P. Rutgeerts, S. Vermeire, K. Verbeke, 2014, Gut.

Butyricicoccus pullicaecorum in inflammatory bowel disease

S. Vermeire, F. Haesebrouck, V. Eeckhaut, 2012, Gut.

Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?

J. Raes, S. Vermeire, K. Verbeke, 2021, EBioMedicine.

Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades

S. Vermeire, M. Ferrante, G. Van Assche, 2019, European journal of gastroenterology & hepatology.

Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC

K. Van Steen, P. Rutgeerts, S. Vermeire, 2015, Gut.

Community types of the human gut virome are associated with endoscopic outcome in ulcerative colitis

J. Raes, G. Falony, J. Matthijnssens, 2022, medRxiv.

Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease.

P. Rutgeerts, S. Vermeire, I. Cleynen, 2019, Journal of Crohn's & colitis.

Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC

P. Rutgeerts, S. Vermeire, I. Cleynen, 2016, Gut.

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

J. Raes, G. Falony, S. Vermeire, 2016, Gut.

Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis

P. Rutgeerts, S. Vermeire, I. Cleynen, 2011, Gut.

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease

S. Vermeire, I. Cleynen, M. Ferrante, 2021, Inflammatory bowel diseases.

High Efficacy of Panobinostat Towards Human Gastrointestinal Stromal Tumors in a Xenograft Mouse Model

P. Atadja, R. Sciot, G. Floris, 2009, Clinical Cancer Research.

Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease

Y. Moreau, J. Vermeesch, C. Robberecht, 2016, Inflammatory bowel diseases.

A microbial signature for Crohn's disease

Harry Sokol, Francisco Guarner, Kathleen Machiels, 2017, Gut.

Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach

C. Manichanh, N. Borruel, F. Casellas, 2021, Computational and structural biotechnology journal.

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

Jan Verhaegen, Paul Rutgeerts, Kathleen Machiels, 2013, Gut.

Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting

C. Manichanh, N. Borruel, F. Casellas, 2021, mSystems.

Early Postoperative Endoscopic Recurrence in Crohn’s Disease Is Characterised by Distinct Microbiota Recolonisation

C. Manichanh, S. Vermeire, M. Ferrante, 2020, Journal of Crohn's & colitis.

Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host Interactions

S. Vermeire, T. Korcsmáros, P. Sudhakar, 2021, Frontiers in Microbiology.

Computational Biology and Machine Learning Approaches to Study Mechanistic Microbiomehost Interactions

Severine Vermeire, Padhmanand Sudhakar, Kathleen Machiels, 2020 .

Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.

J. Raes, P. Rutgeerts, S. Vermeire, 2016, Journal of Crohn's & colitis.

Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC

Kwe Claude Yinda, J. Raes, S. Vermeire, 2017, Gut.

Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment

P. Rutgeerts, S. Vermeire, K. Lemaire, 2011, The American Journal of Gastroenterology.

Sa1922 Pilot Study on the Safety and Efficacy of Faecal Microbiota Transplantation in Refractory Crohn's Disease

F. Hildebrand, J. Raes, P. Rutgeerts, 2012 .

High Acetate Concentration Protects Intestinal Barrier and Exerts Anti-Inflammatory Effects in Organoid-Derived Epithelial Monolayer Cultures from Patients with Ulcerative Colitis

J. Raes, J. Thevelein, S. Vermeire, 2023, International journal of molecular sciences.

Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation

C. Manichanh, S. Vermeire, S. Landolfi, 2020, EBioMedicine.

The Heat Shock Protein 90 Inhibitor IPI-504 Induces KIT Degradation, Tumor Shrinkage, and Cell Proliferation Arrest in Xenograft Models of Gastrointestinal Stromal Tumors

R. Sciot, G. Floris, M. Debiec‐Rychter, 2011, Molecular Cancer Therapeutics.

Preclinical Development The Heat Shock Protein 90 Inhibitor IPI-504 Induces KIT Degradation , Tumor Shrinkage , and Cell Proliferation Arrest in Xenograft Models of Gastrointestinal Stromal Tumors

R. Sciot, G. Floris, M. Debiec‐Rychter, 2011 .

The heat shock protein 90 inhibitor IPI-504 induces KIT degradation , tumor shrinkage and cell proliferation arrest in xenografts models of gastrointestinal stromal tumors

R. Sciot, G. Floris, M. Debiec‐Rychter, 2011 .

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

J. Raes, G. Falony, D. Franchimont, 2022, Gastroenterology.

OP03 Standardized faecal microbiota transplantation with microbiome-guided donor selection in active UC patients: A randomized, placebo-controlled intervention study

J. Raes, G. Falony, D. Franchimont, 2022, Journal of Crohn's and Colitis.

Integrated miRNA and mRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis

P. Rutgeerts, S. Vermeire, K. Lemaire, 2014, PloS one.

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

P. Rutgeerts, S. Vermeire, M. Ferrante, 2014, Inflammatory bowel diseases.

Neutrophil Gelatinase B–associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Serum Marker of Mucosal Healing in Ulcerative Colitis

P. Rutgeerts, S. Vermeire, M. Ferrante, 2014, Inflammatory bowel diseases.

Efficacy of IPI-504 “a novel inhibitor of heat shock protein 90” in a preclinical mouse model of gastro intestinal stromal tumor (GIST)

R. Sciot, G. Floris, M. Debiec‐Rychter, 2009 .

DOP080 Low viral richness at baseline in ulcerative ulcerative colitis associated with faecal microbiota transplantation success.

J. Raes, S. Vermeire, P. Maes, 2017, Journal of Crohn's & colitis.

DOP044 Relationship between microbiota and development of early postoperative Crohn's disease recurrence.

C. Manichanh, P. Rutgeerts, S. Vermeire, 2017, Journal of Crohn's & colitis.

Assessment of the heat shock protein 90 (HSP90) inhibitor IPI504 alone or in combination with the tyrosine kinase inhibitor (TKI) imatinib in mice carrying xenografts of human gastrointestinal stromal tumors (GIST).

R. Sciot, P. Schőffski, M. Debiec‐Rychter, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract #4692: Efficacy of IPI-504 \#8220;a novel inhibitor of heat shock protein 90\#8221; in a preclinical mouse model of gastrointestinal stromal tumor (GIST)

R. Sciot, G. Floris, M. Debiec‐Rychter, 2009 .

The Heat Shock Protein 90 Inhibitor IPI-504 Induces KIT Degradation, Tumor Shrinkage, and Cell Proliferation Arrest in Xenograft Models of Gastrointestinal Stromal Tumors

R. Sciot, G. Floris, G. Faa, 2011, Molecular Cancer Therapeutics.

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

J. Raes, G. Falony, S. Vermeire, 2016, Gut.